Pulmonary hypertension during pregnancy is associated with considerable risks of maternal
mortality and morbidity. Our systematic review of the literature on the use of targeted …

Pulmonary hypertension remains a major cause of cardiac maternal death in the developed
world. Over the last two decades, effective therapies for pulmonary hypertension have been …

Pulmonary hypertension is a syndrome infrequently associated with pregnancy. Despite
advancements in therapy during the past 25 years and encouraging reports of improved …

Women with pulmonary hypertension have a high risk of morbidity and mortality during
pregnancy. The inability to increase cardiac output leads to heart failure while further risks …

Pulmonary hypertension is a medical condition characterized by elevated pulmonary arterial
pressure and secondary right heart failure. Pulmonary arterial hypertension is a subset of …

Pregnancy is hazardous with pulmonary arterial hypertension, but maternal mortality may
have fallen in recent years. We sought to systematically evaluate pulmonary arterial …

Pulmonary hypertension (PH) is a disease, which targets the pulmonary vasculature
affecting the heart and the lungs, and is characterized by a vast array of signs and …

Please cite this paper as: Kiely D, Condliffe R, Webster V, Mills G, Wrench I, Gandhi S, Selby
K, Armstrong I, Martin L, Howarth E, Bu'Lock F, Stewart P, Elliot C. Improved survival in …

Despite advanced therapies, maternal mortality in women with pulmonary arterial
hypertension (PAH) remains high in pregnancy and is especially high during the post …

Pregnancy outcomes in patients with pulmonary hypertension remain poor despite
advanced therapies. Although consensus guidelines recommend against pregnancy in …